Tango Therapeutics has reported an 82% objective response rate with [...]

The FDA is seeking public feedback on plans to tailor [...]

AltruBio has reported Phase 2a results for ALTB-268 in patients [...]

A peer-reviewed study has found a significant correlation between Olink [...]

Aravax will present topline Phase 2 clinical trial results for [...]

AstraZeneca’s Trixeo has been approved in the EU as a [...]

MaaT Pharma plans to advance a global Phase 3 trial [...]

Saudi Arabia has announced more than SAR 5 billion in [...]

AI and Robust Scientific Foundations to Optimize Clinical Trial Operations [...]

A systematic review of more than two decades of clinical [...]